BIOCONTAINMENT
Southern Research’s ability to screen infectious agents requiring BSL-3 containment is unique among HTS centers. Our efforts significantly contributed to the fight against Covid-19, and we are continuously adding to our antiviral assay offerings.
EXPERIENCE
Our HTS Center was one of ten centers selected to serve in the Molecular Libraries Screening Center Network (MLSCN) as part of the Molecular Libraries Initiative component of the NIH roadmap. During the last ten years, the SR HTS team has worked on over 100 campaigns employing more than 300 distinct assays returning results for more than 22 million samples.
CONSULTATIVE SOLUTIONS
Our collaborators and clients have direct access to subject matter experts and others involved in their projects. We want to provide you with the best solution, which equates to the development of biologically relevant assays and the delivery of quality data. We take time to understand your needs to ensure your project is designed to meet those needs.
FLEXIBILITY
We will assist you in designing studies that rigorously test your hypotheses and determine if milestones can be confidently met. We can structure your project to proceed based on go/no-go checkpoints through multiple stages of discovery, including target identification to preclinical studies. We can also operate through a blinded fashion, providing in vitro assay support for client-supplied compounds, allowing you to gain valuable insight into the activity of your compounds that are being profiled.
